Development of chemical isotope labeling liquid chromatography mass spectrometry for silkworm hemolymph metabolomics

Silkworm (Bombyx mori) is a very useful target insect for evaluation of endocrine disruptor chemicals (EDCs) due to mature breeding techniques, complete endocrine system and broad basic knowledge on developmental biology. Comparative metabolomics of silkworms with and without EDC exposure offers another dimension of studying EDCs. In this work, we report a workflow on metabolomic profiling of silkworm hemolymph based on high-performance chemical isotope labeling (CIL) liquid chromatography mass spectrometry (LC-MS) and demonstrate its application in studying the metabolic changes associated with the pesticide dichlorodiphenyltrichloroethane (DDT) exposure in silkworm. Hemolymph samples were taken from mature silkworms after growing on diet that contained DDT at four different concentrations (1, 0.1, 0.01, 0.001 ppm) as well as on diet without DDT as controls. They were subjected to differential ¹²C-/¹³C-dansyl labeling of the amine/phenol submetabolome, LC-UV quantification of the total amount of labeled metabolites for sample normalization, and LC-MS detection and relative quantification of individual metabolites in comparative samples. The total concentration of labeled metabolites did not show any significant change between four DDT-treatment groups and one control group. Multivariate statistical analysis of the metabolome data set showed that there was a distinct metabolomic separation between the five groups. Out of the 2044 detected peak pairs, 338 and 1471 metabolites have been putatively identified against the HMDB database and the EML library, respectively. 65 metabolites were identified by the dansyl library searching based on the accurate mass and retention time. Among the 65 identified metabolites, 33 positive metabolites had changes of greater than 1.20-fold or less than 0.83-fold in one or more groups with p-value of smaller than 0.05. Several useful biomarkers including serine, methionine, tryptophan, asymmetric dimethylarginine, N-Methyl-D-aspartic and tyrosine were identified. The changes of these biomarkers were likely due to the disruption of the endocrine system of silkworm by DDT. This work illustrates that the method of CIL LC-MS is useful to generate quantitative submetabolome profiles from a small volume of silkworm hemolymph with much higher coverage than conventional LC-MS methods, thereby facilitating the discovery of potential metabolite biomarkers related to EDC or other chemical exposure.     

LC-MS/MS Assay for Quantification of a Novel Antidiabetic Flavone Derivative S002-857 in Rat Plasma, Urine and Feces: Application in Pharmacokinetic Studies

This study aimed to develop an LC-MS/MS assay for the quantitation of S002-857 in plasma, urine and feces to evaluate the pharmacokinetic parameters and elimination pathway for further development of S002-857. A sensitive and selective LC-MS/MS method was developed and validated for estimating a novel antidiabetic flavone derivative, S002-857, synthesized by Central Drug Research Institute, CSIR, Lucknow, India. Plasma and urine samples were prepared by two-step liquid-liquid extraction with diethyl ether and feces by protein precipitation using acetonitrile. The analyte was chromatographed on a cyano column with methanol-ammonium acetate buffer (pH 4.6, 10 mM; 90:10, v/v). The calibration curves were linear over a range of 0.78?C400 ng mL^?1 for plasma and 1.56?C400 ng mL^?1 for urine and feces samples. The accuracy and precision were <15% for plasma, urine and feces samples. The recoveries from spiked plasma, urine and feces samples were >85%. S002-857 was stable in plasma for 8 h at ambient temperature, 30 days at ?60 °C and after three freeze-thaw cycles. The assay was successfully applied to determine the pharmacokinetic parameters and excretion profile in male rats.     

Modifier-assisted differential mobility–tandem mass spectrometry method for detection and quantification of amphetamine-type stimulants in urine

An advantage of differential mobility spectrometry (DMS) is it provides an orthogonal mechanism to mass spectrometry (MS). The DMS-MS/MS detects analytes in the gas phase on the basis of differences in ion mobility in low and high electric fields, which makes DMS-MS/MS an alternative to chromatographic separation-MS. One drawback of DMS is its limited resolution and sensitivity, especially for detecting small molecules when using a nonpolar inert gas as the carrier gas. The present work has evaluated the effects on peak capacity of adding chemical modifiers to inert carrier gases (nitrogen, helium, argon and carbon dioxide). Use of a methanol-helium mixture gave improvements in both separation and sensitivity. Nine structurally similar amphetamine-type stimulants were determined in urine without pretreatment of the samples before analysis. After optimization of carrier gas, nature and concentration of chemical modifier, and DMS temperature, limits of detection ranging from 1.1 to 2.7 ng mL⁻¹, with a linear range of three orders of magnitude (5–5000 ng mL⁻¹) were achieved. Precision was <15% and the accuracy of the quality control samples was 87.6–113.7%. For the quantitation of urine samples from drug abusers, data obtained using DMS-MS/MS showed reasonable agreement (within ±19.5%) with that obtained using LC-MS/MS. The analysis time for DMS-MS/MS was only 1.1 min and a paired sample t-test between the two methods gave a p-value of 0.0894, which indicates that DMS-MS/MS is a reliable method, with comparable precision and sensitivity to LC-MS/MS.     

A novel miniaturized zinc oxide/hydroxylated multiwalled carbon nanotubes as a stir-brush microextractor device for carbamate pesticides analysis

A novel miniaturized “stir-brush microextractor” was prepared using a zinc oxide/hydroxylated multiwalled carbon nanotubes (ZnO/MWCNTs–OH) coated stainless steel brush connected to a small dc motor. The synthesized zinc oxide on each strand of stainless steel had a flower-like nanostructure when observed by a scanning electron microscope (SEM). This structure produced a large surface area before it was coated with the hydroxylated multiwalled carbon nanotubes sorbent. Under optimal conditions, the developed device provided a good linearity for the extraction of carbofuran and carbaryl, in the range of 25–500 ng mL⁻¹ and 50–500 ng mL⁻¹, respectively, with low limits of detection of 17.5 ± 2.0 ng mL⁻¹ and 13.0 ± 1.8 ng mL⁻¹. It also provided a good stir-brush-to-stir-brush reproducibility (% relative standard deviation < 5.6%, n = 6). The device was applied for the extraction and preconcentration of carbamate pesticides in fruit and vegetable samples prior to analysis with a gas chromatograph coupled with a flame ionization detector (GC–FID). Carbofuran was found at 9.24 ± 0.93 ng g⁻¹ and carbaryl was detected at 7.05 ± 0.61 ng g⁻¹ with good recoveries in the range of 73.7 ± 10.0% to 108.4 ± 2.6% for carbofuran and 75.7 ± 10.0% to 111.7 ± 5.7% for carbaryl.     

Determination of Eprinomectin in Bovine Urine and Feces Using HPLC with Fluorescence Detection

Eprinomectin is a novel and potent antiparasitic animal health drug. An analytical procedure for the determination of EPR in bovine urine and feces has been developed. The urine sample was centrifuged and alkalized with ammonia following solid phase extraction. The fecal sample was extracted with acetonitrile, defatted with hexane, cleaned-up using C18 cartridge. All samples were analyzed by high performance liquid chromatography with fluorescence detection after derivatization with N-methylimidazole. The limits of detection are 0.5 ng mL⁻¹ and 0.5 ng g⁻¹, respectively. Fortified at 2, 10, 50, and 100 ng mL⁻¹(ng g⁻¹), inter-assay recoveries of EPR in cattle urine and feces were in the range of 87.9–91.5% and 78.6–86.3%, with coefficients of variation of 5.4–10.2% and 1.4–7.2%, respectively. Intra-assay mean recoveries of the analytes were 82.2–86.5% and 79.6–87.3%, with coefficients of variation of 7.8–11.5% and 6.3–7.8%, respectively. The method was used to study the excretion of eprinomectin in bovine urine and feces after subcutaneous administration at a dose of 0.5 mg kg⁻¹.     

Two low-cost digital camera-based platforms for quantitative creatinine analysis in urine

In clinical analysis creatinine is a routine biomarker for the assessment of renal and muscular dysfunctions. Although several techniques have been proposed for a fast and accurate quantification of creatinine in human serum or urine, most of them require expensive or complex apparatus, advanced sample preparation or skilled operators. To circumvent these issues, we propose two home-made platforms based on a CD Spectroscope (CDS) and Computer Screen Photo-assisted Technique (CSPT) for the rapid assessment of creatinine level in human urine. Both systems display a linear range (r² = 0.9967 and 0.9972, respectively) from 160 μmol L⁻¹ to 1.6 mmol L⁻¹ for standard creatinine solutions (n = 15) with respective detection limits of 89 μmol L⁻¹ and 111 μmol L⁻¹. Good repeatability was observed for intra-day (1.7–2.9%) and inter-day (3.6–6.5%) measurements evaluated on three consecutive days. The performance of CDS and CSPT was also validated in real human urine samples (n = 26) using capillary electrophoresis data as reference. Corresponding Partial Least-Squares (PLS) regression models provided for mean relative errors below 10% in creatinine quantification.     

The pharmacokinetic characteristics and excretion studies of fucosterol from Sargasssum fusiforme in rats

Fucosterol is the main phytosterol in brown algae with various pharmacological effects such as cholesterol-lowering, anticancer, hepatoprotection and neuroprotection. Little is known about the pharmacokinetics and excretion characteristics of fucosterol. In this study, a GC–MS method was developed and validated for the determination of fucosterol in rat plasma, urine and feces. The method effectively avoids the interference of Δ⁵-avenasterol, a cis–trans-isomer of fucosterol derived from feed, by using a TG-5 capillary column (a nonpolar column with 5% phenyl-methylpolysilicone as stationary phase material). The linearity ranges were fucosterol 0.300–18.0 μg/ml (R² = 0.9960) for plasma, 0.0500–2.50 μg/ml for the urine sample (R² = 0.9963) and 0.100–8.00 μg/mg (R² = 0.9923) for the feces sample. With good extraction recoveries and stability, this rapid and sensitive method was successfully applied to the pharmacokinetic and excretion studies of fucosterol in Sprague–Dawley rats. Fucosterol from Sargassum fusiforme had poor absorption and slow elimination with an absolute oral bioavailability of 0.74%, and was mainly eliminated through fecal excretion.     

A Comparative Study of Pentafluorophenyl and Octadecylsilane Columns in High‐throughput Profiling of Biological Fluids

In high‐throughput metabolomic profiling, chromatographic separation is crucial because a well‐performed chromatographic separation may reduce signal suppression from complex biological matrices and improve the discoverability of low‐abundance metabolites. We compared the performance of pentafluorophenyl (PFP )‐ and octadecylsilane (ODS )‐based columns in profiling biological fluids. Peak resolutions and consistencies were acquired using several reversed‐phase columns and were evaluated. Total and extracted ion chromatograms demonstrated that the PFP column achieved better analyte separations than the ODS column. Low relative standard deviations on peak areas and retention times (<10.2 and <0.9%, respectively) acquired using the PFP column evidenced the high reproducibility and consistency of this column. In our study, a PFP column was used for profiling metabolomes extracted from urine and serum samples. Metabolomic study revealed a metabolome difference in normal and overweight participants. In total, 26 lipid species were significantly perturbed and further identified. Choline‐containing lipids were the most abundant perturbed lipidome in overweight participants, followed by sphingolipids and various phospholipids. We recommend the use of PFP columns in high‐throughput metabolomic analysis to promote the development of basic biological and clinical research in the future.     

A disposable chronocoulometric sensor for heavy metal ions using a diaminoterthiophene-modified electrode doped with graphene oxide

The rapid simultaneous determination of cadmium, lead, copper, and mercury ions is performed by employing a disposable sensor modified with graphene oxide (GO) doped diaminoterthiophene (GO/DTT) for chronocoulometry (CC). The performances of CC with and without pre-deposition in two opposite potential step directions were compared with square wave anodic stripping voltammetry (SWASV) under various conditions. The surface of the GO/DTT modified screen print carbon electrode (SPCE) was characterized by SEM, EDXS, and electrochemical impedance spectroscopy (EIS). Experimental variables that affect the response signal such as the pH, deposition time, type of supporting electrolyte, concentration of DTT, content ratio of GO to DTT, and Nafion content were optimized. Interference effects due to other heavy metal ions were also investigated. The dynamic ranges of SWASV and CC were between 1 ng mL⁻¹ and 2.5 μg mL⁻¹ and between 1 ng mL⁻¹ and 10 μg mL⁻¹, respectively. The detection limits for Cd²⁺, Pb²⁺, Cu²⁺, Hg²⁺ ions were 1.9 ± 0.4 ng mL⁻¹, 2.8 ± 0.6 ng mL⁻¹, 0.8 ± 0.2 ng mL⁻¹, and 2.6 ± 0.9 ng mL⁻¹ for the CC stripping method; 2.6 ± 0.2 ng mL⁻¹, 0.5 ± 0.1 ng mL⁻¹, 1.8 ± 0.3 ng mL⁻¹, and 3.2 ± 0.3 ng mL⁻¹ for the CC deposition method; and 7.1 ± 0.9, 1.9 ± 0.3, 0.4 ± 0.1, and 0.7 ± 0.1 ng mL⁻¹ for SWASV. The reliability of the method for point-of-analysis was evaluated by analyzing a urine standard reference material and some water samples.     

A new sample preparation and separation combination for precise,accurate, rapid,and simultaneous determination of vitamins B1, B2, B3, B5, B6, B7, and B9 in infant formula and related nutritionals by LC-MS/MS

An improved method was developed for simultaneous determination of the fortified forms of thiamine (B₁), riboflavin (B₂), nicotinamide and nicotinic acid (B₃), pantothenic acid (B₅), pyridoxine (B₆), biotin (B₇), and folic acid (B₉) in infant formulas and related nutritionals. The method employed a simple, effective, and rapid sample preparation followed by liquid chromatography tandem mass spectrometry (LC-MS/MS). It improved upon previous methodologies by offering facile and rugged sample preparation with improved chromatographic conditions, which culminated in a highly accurate and precise method for water-soluble vitamin determination in a wide range of formulas. The method was validated over six days in ten unique matrices with two analysts and on instruments in two different labs. Intermediate precision averaged 3.4 ± 2.6% relative standard deviation and over-spike recovery averaged 100.2 ± 2.4% (n = 160). Due to refinements in sample preparation, the method had high sample throughput capacity.     

Characterization of Metabolites in Plasma,Urine and Feces of Healthy Participants after Taking Brahmi Essence for Twelve Weeks Using LC-ESI-QTOF-MS Metabolomic Approach

Brahmi essence, developed from Bacopa monnieri (L.) Wettst. standardized extract and mulberry juice, was proven to improve the memory speed of healthy participants aged 55–80 years old, following a 12-week dietary program. However, the metabolites have not yet been reported. Our objective was to characterize the altered metabolites in the plasma, urine, and feces of healthy volunteers after consumption of Brahmi essence for 12 weeks, using the LC-MS metabolomics approach. The altered metabolites were selected from OPLS-DA S-plots; 15 metabolites in the plasma, 7 in the urine, and 17 in the feces samples were tentatively identified by comparison with an online database and literature. The metabolites in the plasma samples were in the classes of amino acids, acylcarnitine, and phospholipids. Benzeneactamide-4-O-sulphate and 3-hydroxyhippuric acid were found in urine samples. The metabolites in the class of amino acids, together with jujubogenin and pseudojujubogenin, were identified in the fecal samples. The aminoacyl-tRNA, aromatic amino acids, and branched-chain amino acid biosynthetic pathways were mainly related to the identified metabolites in all three samples. It could be implied that those metabolites and their pathways might be linked with the effect of Brahmi essence on memory speed.     

Preliminary study to prepare a reference material of toluene metabolite – o-cresol and benzene metabolite-phenol – in human urine

The candidate reference material (RM) was prepared by freeze-drying pooled urine samples obtained from healthy persons occupationally exposed to toluene. Homogeneity testing yielded no significant differences of urinary concentrations of o-cresol and phenol in 15 randomly selected units of RM. Stability testing showed no significant changes of concentrations of the above analytes over a period of 6 months. Property (pre-certified) values of phenol and o-cresol concentrations and their uncertainties (9.06±0.47 mg l⁻¹ and 1.03±0.06 mg l⁻¹, respectively) were estimated from results of a small-scale interlaboratory comparison in which two laboratories participated using four different analytical methods.     

An eco‐friendly water‐soluble fluorene‐based polyelectrolyte as interfacial layer for efficient inverted polymer solar cells

A conjugated polyelectrolyte poly(9,9‐bis(3′‐[(N,N‐dimethyl)‐N‐ethylammonium]‐propyl)‐2,7‐fluorene dibromide) (PFBr) with the feature of environmental friendliness and cheapness was successfully used in polymer solar cells (PSCs) as the cathode interfacial layer (CIL). And we successfully demonstrate that the PFBr can build interfacial dipoles at the CIL/cathode interfaces, leading to reduce cathode work functions and improve open‐circuit voltages, which decrease interfacial energy loss at the cathode. It not only improves the electron transfer efficiency but also inhibits the charge carrier recombination at the contact interface. Impedance spectra revealed that the optimal device with the smallest charge transport time constant of 2.83 microseconds was achieved under the concentration of 2 mg mL⁻¹ of PFBr, which suggests efficient electron transport on the interface between the organic active layer and the indium tin oxide cathode. Moreover, as a consequence, the power conversion efficiency of the PSCs increases to 3.83% (with PFBr as CIL) from 1.89% (without any CIL), based on the poly(3‐hexylthiophene) and [6,6]‐phenyl C₆₁‐butyric acid methyl ester bulk heterojunction active layer. Therefore, our observation can demonstrate PFBr is a prospective candidate as CIL for constructing low‐cost, large‐area, and flexible PSCs.     

Metabolic effects of Hedyotis diffusa on rats bearing Walker 256 tumor revealed by NMR‐based metabolomics

Hedyotis diffusa, a traditional Chinese herbal medicine, is widely used for oncotherapy and shows a positive effect in the clinical treatment. But its mechanism of anticancer activities is complicated and unclear. This study was undertaken to assess the therapeutic effects and reveal detailed mechanisms of H. diffusa for oncotherapy. A Walker 256 tumor‐bearing rat model was established, and metabolomic profiles of plasma and urine were obtained from ¹H NMR technique. Multivariate statistical analysis methods were used to characterize the discriminating metabolites between control (C), Walker 256 tumor‐bearing rats model (M), and H. diffusa treatment (H) groups. Finally, 13 and 10 metabolomic biomarkers in urine and plasma samples were further identified as characteristic metabolites in M group, whereas H group showed a partial metabolic balance recovered, such as ornithine, N‐acetyl‐l ‐aspartate, l ‐aspartate, and creatinine in urine samples, and acetate, lactate, choline, l ‐glutamine, and 3‐hydroxybutyrate in plasma samples. On the basis of the methods above, we hypothesized H. diffusa treatment reduced the injury caused by Walker 256 tumor and maintained a metabolic balance. Our study demonstrated that this method provided new insights into metabolic alterations in tumor‐bearing biosystems and researching on the effects of H. diffusa on the endogenous metabolism in tumor‐bearing rats.     

Bioanalysis of bevacizumab and infliximab by high-temperature reversed-phase liquid chromatography with fluorescence detection after immunoaffinity magnetic purification

This study presents two simple and rapid methods for the quantification of therapeutic mAbs based on LC. Two mAbs (bevacizumab and infliximab) in plasma samples were purified using magnetic beads immobilized with a commercially-available idiotype antibody for each mAb. Purified mAbs were separated with HT-RPLC and detected with their native fluorescence. Using immunoaffinity beads, each mAb was selectively purified and detected as a single peak in the chromatogram. The HT-RPLC achieved good separation for the mAbs with sharp peaks within 20 min. The calibration curves of the two mAbs ranged from 1 to 20 μg mL⁻¹ (bevacizumab) and 1–10 μg mL⁻¹ (infliximab), and they had strong correlation coefficients (r² > 0.998). The LOD of bevacizumab and infliximab was 0.07 and 0.15 μg mL⁻¹, and the LLOQ of bevacizumab and infliximab was 0.12 and 0.25 μg mL⁻¹, respectively. Thus, the sensitivities were sufficient for clinical analysis. Immunoaffinity purification with HT-RPLC produced a selective and accurate bioanalysis without an LC-MS/MS instrument. Both methods could become general-purpose analytical methods and complement the results obtained with conventional LBA.     

Direct quantification of deoxynivalenol glucuronide in human urine as biomarker of exposure to the <Emphasis Type="Italic">Fusarium</Emphasis> mycotoxin deoxynivalenol

The direct quantification of deoxynivalenol glucuronide (DON-GlcA) by liquid chromatography-tandem mass spectrometry (LC-MS/MS) and its application as a biomarker of exposure to the Fusarium mycotoxin deoxynivalenol (DON) is reported. Usually, DON exposure is estimated from dietary average intakes or by measurement of the native toxin in urine after enzymatic hydrolysis with β-glucuronidase. These methods are time-consuming, expensive, and fail to determine the ratio of DON to DON-GlcA in a simple one-step procedure. One of the main reasons for the use of indirect methods is the unavailability of DON-GlcA standards. Consequently, DON-3-O-glucuronide (D3GlcA) was synthesized and used to develop a method allowing quantification of both DON and D3GlcA by a simple “dilute and shoot” approach without the need for any cleanup. Limit of detection and apparent recovery of D3GlcA was 3 μg l⁻¹ and 88%, respectively. The identity of D3GlcA in human urine was confirmed by comparison with LC-MS/MS measurements of the synthetically produced D3GlcA standard which was also used for external calibration. The applicability of the method was demonstrated through the analysis of urine samples obtained from a volunteer during regular and cereal-restricted diet, respectively. In regular-diet urine samples, D3GlcA was quantified in concentrations >30 μg l⁻¹ by this approach.     

Determination of amlodipine besylate by adsorptive square-wave anodic stripping voltammetry on glassy carbon electrode in tablets and biological fluids

The adsorptive and electrochemical behavior of amlodipine besylate on a glassy carbon electrode were explored in Britton-Robinson buffer solution by using cyclic and square-wave voltammetry. Cyclic voltammetric studies indicated the oxidation of amlodipine besylate at the electrode surface through a single two-electron irreversible step and fundamentally controlled by adsorption. The solution conditions and instrumental parameters were optimized for the determination of the authentic drug by adsorptive square-wave stripping voltammetry. Amlodipine besylate gave a sensitive adsorptive oxidation peak at 0.510 V (versus Ag/AgCl). The oxidation peak was used to determine amlodipine besylate in range 4.0×10⁻⁸ to 2.0×10⁻⁶ with a detection limit of 1.4×10⁻⁸ M. The procedure was successfully applied for the assay of amlodipine besylate in tablets (Norvasc)^®. The percentage recoveries were in agreement with those obtained by the reference method. Applicability to assay the drug in urine and serum samples was illustrated. The mean percentage recoveries were 96.31±1.18 and 96.98±1.17, respectively. The proposd method used for monotoring clinically relevant concntrations of drug in human urine and serum.     

An isotope-labeled chemical derivatization method for the quantitation of short-chain fatty acids in human feces by liquid chromatography–tandem mass spectrometry

Short-chain fatty acids (SCFAs) are produced by anaerobic gut microbiota in the large bowel. Qualitative and quantitative measurements of SCFAs in the intestinal tract and the fecal samples are important to understand the complex interplay between diet, gut microbiota and host metabolism homeostasis. To develop a new LC-MS/MS method for sensitive and reliable analysis of SCFAs in human fecal samples, 3-nitrophenylhydrazine (3NPH) was employed for pre-analytical derivatization to convert ten C₂–C₆ SCFAs to their 3-nitrophenylhydrazones under a single set of optimized reaction conditions and without the need of reaction quenching. The derivatives showed excellent in-solution chemical stability. They were separated on a reversed-phase C₁₈ column and quantitated by negative-ion electrospray ionization – multiple-reaction monitoring (MRM)/MS. To achieve accurate quantitation, the stable isotope-labeled versions of the derivatives were synthesized in a single reaction vessel from ¹³C₆-3NPH, and were used as internal standard to compensate for the matrix effects in ESI. Method validation showed on-column limits of detection and quantitation over the range from low to high femtomoles for the ten SCFAs, and the intra-day and inter-day precision for determination of nine of the ten SCFAs in human fecal samples was ≤8.8% (n = 6). The quantitation accuracy ranged from 93.1% to 108.4% (CVs ≤ 4.6%, n = 6). This method was used to determine the SCFA concentrations and compositions in six human fecal samples. One of the six samples, which was collected from a clinically diagnosed type 2 diabetes patient showed a significantly high molar ratio of branch-chain SCFAs to straight-chain SCFAs than the others. In summary, this work provides a new LC-MS/MS method for precise and accurate quantitation of SCFAs in human feces.     

Flow method based on cloud point extraction for fluorometric determination of epinephrine in human urine

A novel stepwise injection fluorometric method for the determination of epinephrine in human urine has been developed. In the current study, the stepwise injection analysis (SWIA) was successfully combined with on-line in-syringe cloud point extraction (CPE) and fluorometric detection. The procedure was based on the epinephrine derivatization in the presence of o-phenylenediamine followed by the preconcentration stage based on the CPE with the nonionic surfactant Triton X-114. After the phase separation into a syringe of the flow system, the micellar phase containing the epinephrine derivative was transported to a fluorometric detector. The excitation and emission wavelengths were set at 447 nm and 550 nm, respectively. The conditions of epinephrine derivatization and CPE have been studied. The calibration plot constructed using the developed procedure was linear in the range of 1·10⁻¹¹–5·10⁻⁷ mol L⁻¹. The limit of detection, calculated as 3 σ of a blank test (n = 10), was found to be 3·10⁻¹² mol L⁻¹. The proposed method was successfully applied for the determination of epinephrine in human urine samples.